Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrick Stoiber"'
Autor:
Patrick Stoiber, Pietro Scribani Rossi, Niranjana Pokharel, Jean-Luc Germany, Emily A. York, Scott E. Schaus, Ulla Hansen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Factor quinolinone inhibitors are promising anti-cancer compounds, initially characterized as specific inhibitors of the oncogenic transcription factor LSF (TFCP2). These compounds exert anti-proliferative activity at least in part by disrup
Externí odkaz:
https://doaj.org/article/17bb4586a609471589a4fe4bbe029ae8
Autor:
Jennifer L. S. Willoughby, Kelly George, Mark P. Roberto, Hang Gyeong Chin, Patrick Stoiber, Hyunjin Shin, Chandra Sekhar Pedamallu, Scott E. Schaus, Kevin Fitzgerald, Jagesh Shah, Ulla Hansen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background The oncogene LSF (encoded by TFCP2) has been proposed as a novel therapeutic target for multiple cancers. LSF overexpression in patient tumors correlates with poor prognosis in particular for both hepatocellular carcinoma and colo
Externí odkaz:
https://doaj.org/article/78196f74ff6642ea90ac3be30f035d7e
Autor:
Jagesh V. Shah, Scott E. Schaus, Hyunjin Shin, Chandra Sekhar Pedamallu, Patrick Stoiber, Hang Gyeong Chin, Jennifer L.S. Willoughby, Mark P. Roberto, Kelly George, Ulla Hansen, Kevin Fitzgerald
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Cancer
BMC Cancer
Background The oncogene LSF (encoded by TFCP2) has been proposed as a novel therapeutic target for multiple cancers. LSF overexpression in patient tumors correlates with poor prognosis in particular for both hepatocellular carcinoma and colorectal ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::583c229510c0f8416c29b009c689db12
https://doi.org/10.1186/s12885-020-07039-1
https://doi.org/10.1186/s12885-020-07039-1
Autor:
Iriny Ekladious, Yolonda L. Colson, Qing Zhao, Patrick Stoiber, Scott E. Schaus, Mark W. Grinstaff, Ulla Hansen
Publikováno v:
Biomacromolecules. 21(4)
Expansile nanoparticles (eNPs) are a promising pH-responsive polymeric drug delivery vehicle, as demonstrated in multiple intraperitoneal cancer models. However, previous delivery routes were limited to intraperitoneal injection and to a single agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084b6af769860c0d3e07c693abe2941a
https://pubmed.ncbi.nlm.nih.gov/32101401
https://pubmed.ncbi.nlm.nih.gov/32101401